HIGHLIGHTS
- who: PPARš¯›¾/RXR Heterodimerization and colleagues from the College of Food Science, Fujian Agriculture and Forestry University, Fuzhou, Fujian, China have published the research work: Expression of GPR43 in Brown Adipogenesis Is Enhanced by Rosiglitazone and Controlled by PPAR š¯›¾ /RXR Heterodimerization, in the Journal: PPAR Research of 16/05/2018
- what: The authors investigated the effects of the PPARš¯›¾ agonist rosiglitazone on GPR43 expression in brown adipogenesis.
- how: The results showed that cotreatment of HX531 with rosiglitazone also effectively inhibited rosiglitazone-induced GPR43 expression in brown adipocytes . The result showed that the knockdown . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.